3 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Unknown 3 |
Follow HBV: new trials by email Literature Review of HBV trials Research Report on HBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept Study Hepatect CP 50 I.E./ml infusion solution - Hepatocellular Carcinoma, HBV | Not applicable | Unknown | Medical University of Graz | 5 | 2024-11-01 | 2024-01-18 |
| The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM) TRI-MOM intervention - Hiv, Syphilis | Not applicable | Unknown | Institut de Recherche pour le Developpement | 2800 | 2024-03-18 | 2024-06-20 |
| Tenofovir Alafenamide for HBV Prophylaxis in HBV(-) Liver Transplant Recipients With HBcAb+ Donors Tenofovir Alafenamide 25 MG - HBV, Liver Transplant Disorder | Not applicable | Unknown | RenJi Hospital | 30 | 2021-04-01 | 2021-01-11 |
Acquired Immunodeficiency Syndrome (1) · Carcinoma, Hepatocellular (1) · Hepatitis B (1) · Syphilis (1)
Digestive System Diseases (2) · Liver Diseases (2) · Adenocarcinoma (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Carcinoma (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Digestive System Neoplasms (1) · Genital Diseases (1) · Gram-Negative Bacterial Infections (1) · HIV Infections (1) · Hepadnaviridae Infections (1) · Hepatitis (1)
Institut de Recherche pour le Developpement (1) · Medical University of Graz (1) · RenJi Hospital (1)
Burkina Faso (1) · The Gambia (1)
Qiang Xia, MD., Ph.D. (1) · Sylvie Boyer, PhD (1) · Zhifeng Xi, MD. (1)